Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Towards A Future Health Service Supply Chain

No description
by

James Carlson

on 28 October 2013

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Towards A Future Health Service Supply Chain

Our healthcare supply chain is inefficient and does not meet the needs of individual patients.
B2B
B2C
supplied by wholesalers and agents
HCPs, Pharmacies
One-off transactions w/undifferentiated populations
Reference: Ernst & Young Progressions Report, 2012, www.ey.com/progressions
Enduring, lifelong relationships with individual customers
Third-party Logistics
Wholesalers
Patient Assistance
Specialty Pharmacy
Intake Hub
Life Science Innovator
Hospital
H
Payers
$
Specialty Pharmacy
Specialty Pharmacy
Patients
Payers
$
Patients
Life Science Innovator
Patients
Value-Driven Supply Chain Models to Meet the Needs of Individual Patients
Outcomes
transparency
Call for a new model
Patients
B2B
B2C
Third-party Logistics
Wholesalers
Local Pharmacy
Life Science Innovator
Hospital
H
Payers
$
Local Pharmacy
Local Pharmacy
Patients
Payers
$
Patients
EVIDENCE
DATA
VALUE =
OUTCOMES
COST
Agile, convenient, matches individual lifestyles
empowerment
aggregated data
improved compliance
opportunity to measure health outcomes
reimbursement
import/export
country regulations
traditional operations
language
direct-to-patient advertising restrictions
Direct to Patient Dispensing
Integrated Services
30 years
13 years
1997
Is this our 1997?
Is this our 1983?

Where will we be in 2023?
It won't be easy...
Healthcare Utilization (per 1000 patients)
Hospital Admissions
ER Visits
MD Visits
Antibiotic Days
208
369
6446
27309
185
288
5872
24335
23
81
574
2974
11
22
9
11
Year 1
Year 2
#
%
“Effects of a Disease Management Program in Patients with Alpha-1 Antitrypsin Deficiency,” Journal of COPD, Feb. 2009

No outcomes = no income
Decrease in Year 2
Integrated Market Access Centers of Excellence across the globe for rare disease populations
Orphan drugs are costly.
Enduring, lifelong relationships with individual customers
Life Science Innovator
Patients
Outcomes
transparency
Agile, convenient, matches individual lifestyles
empowerment
aggregated data
improved compliance
opportunity to measure health outcomes
Exclusive Distribution
Integrated Services
Data Collection
Reimbursement Support
Nurse coordination
Educational Support
Health Management
Outcomes of a Health Management Program
...but it can be done.
"Life science companies will find themselves valued on how well they can adapt their supply chains to meet the preferences and needs of individual patients." - E&Y Progressions Report, 2012
Health Management
Full transcript